Release of Ca2+ by TRPM3 seems to play a central role in NK cells' activation and function as dysregulation of TRPM3 function in ME/CFS patients has been shown to affect Ca2+ signaling, leading to impaired NK cell regulatory machinery and functions. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.